A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.
Long COVID is a serious, growing public health crisis. Though estimates vary, as many as 18 million Americans may be affected. This is why it continues to capture the attention of Senator Todd Young, ...
Christine Taylor shared new details about her separation from Ben Stiller, revealing how years apart, therapy and an ...
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...
HIV patients can be drug-free for up to two years under a treatment that ends the need for daily pills. A new antibody ...
AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...
The Justice Department claims that clinics used fake diagnoses and kickbacks to parents to bring children into treatment.
(NYSE American:NNVC, opens new tab) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results